VOLUME EXPANSION AND FLOW PROMOTION IN SHOCK

被引:6
作者
GRUBER, UF
机构
[1] Department of Surgery, University of Basel
关键词
D O I
10.1136/pgmj.45.526.534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Volume replacement is the most important step in treating hypovolaemic shock. Blood is needed when the oxygen carrying capacity threatens to fall below a critical level, but has the disadvantage of transmitting virus hepatitis. Anicteric hepatitis is about four times more frequent than the icteric form. Pasteurized plasma protein solution and albumin are free from the risk of transmitting hepatitis virus, and are good volume restorers. Dextran 70 represents the best artificial colloid with additional anti-thrombotic properties. Dextran 40 is indicated in special situations to promote flow. There is no proof that large amounts of Ringer solution are superior for treating hypovolaemic shock in mancompared with colloids and electrolytes.
引用
收藏
页码:534 / &
相关论文
共 65 条
[1]  
ANDERSON RW, 1967, SURG FORUM, V18, P32
[2]  
ATIK M, 1967, J AMER MED ASSOC, V200, P540
[3]   LOW MOLECULAR WEIGHT DEXTRAN THERAPY IN SURGICAL SHOCK .2. PATIENTS IN SHOCK TREATED WITH LOW MOLECULAR WEIGHT DEXTRAN [J].
BAKER, RJ ;
SHOEMAKER, WD ;
SUZUKI, F ;
FREEARK, RJ ;
STROHL, EL ;
CAREY, J .
ARCHIVES OF SURGERY, 1964, 89 (02) :379-389
[4]  
BERGENTZ SVEN-ERIK, 1961, ACTA CHIR SCAND, V122, P343
[5]  
BIGELOW W G, 1964, Can J Surg, V7, P237
[6]  
BLOCH JH, 1965, SURGERY, V58, P197
[7]  
BOBA A, 1968, ACTA ANESTH SCAN S31
[8]  
BOLLINGER A, 1968, Z KREISLAUFFORSCH, V57, P456
[9]  
BYGDEMAN S, 1968, ACTA CHIR SCAND S387
[10]  
BYGDEMAN S, 1968, PROGR SURG, V7, P114